Biology & Life Sciences

Magazine articles on biology, life sciences, biotech, medical research.

Old Articles: <Older 971-980 Newer>

Bio-IT World April 2006 Kevin Davies	NitroMed Ties Gene Biomarkers to BiDil Benefit The FDA approval of BiDil, NitroMed's heart failure drug for blacks, raised howls of controversy. Now at a meeting of the American College of Cardiology, researchers presented two papers that offer the first preliminary hints of genetic factors that affect BiDil response.
Bio-IT World April 2006 Robert M. Frederickson	High-Content Cell-Based Imaging Increasingly, equipment providers are incorporating modules for high-content and single-cell analyses into their drug discovery platforms. In addition, new strategies and equipment designs are bringing new types of analysis into the drug discovery marketplace.
Bio-IT World April 2006	News Blast Flu Fighter... Strategic Allies... Open Access... NSF Grant...
Bio-IT World April 2006 Salvatore Salamone	Is caBIG Ready to Bloom? What is the National Cancer Institute's Center for Bioinformatics initiative called the Cancer Biomedical Informatics Grid (caBIG), and why should researchers care?
Bio-IT World April 2006 Mark D. Uehling	Debating Clinical Registries and Databases The pharmaceutical industry has been forced by medical journal editors and Congress to make public more data about clinical trials. Registries are here, most people are used to them, and they're not going away. But can the industry do registries and databases better?
Bio-IT World April 2006	Virtual Stem Cell Laboratory Goes Live Children's Hospital in Boston's Virtual Stem Cell Laboratory web site allows online visitors to manipulate and investigate a "living" culture of embryonic stem cells.
Bio-IT World April 2006 Bill Van Etten	Easing In to Ease of Use The dramatic change in the bioinformatics and related information technology user profile requires an appropriate response from the producers of these technologies to provide a level of "ease of use" that is consistent with the large-volume, low-cost, and less specialized user.
Bio-IT World April 2006 Kevin Davies	BioIT World's New Beginning Cambridge Healthtech Institute, along with its new acquisition of BioIT World, under the new name of Cambridge Bio Collaborative will become the key information and conference resource for the industry.
Bio-IT World April 2006 John Russell	Lobbying for Critical Path Funding The FDA's Critical Path Initiative is an important program in need of cold hard cash and dedicated FDA personnel.
Fast Company April 2006 Chuck Salter	A Prescription for Innovation The Mayo Clinic's new SPARC lab is driving experimentation at the frontier of health care. How? By getting physicians to think more like designers.
<Older 971-980 Newer> Return to current articles.